Abstract
A semen analysis (SA) should be performed on all men of reproductive age prior to the commencement of testosterone supplementation therapy (TST). A baseline SA has numerous benefits including the ability to unmask occult azoospermia, act as a baseline measure of reproductive function, and provide a recovery target for management of TST-induced testicular dysfunction. Physicians treating men of reproductive age with TST should incorporate SA as part of their initial treatment protocol.
Original language | English (US) |
---|---|
Pages (from-to) | 446-447 |
Number of pages | 2 |
Journal | Journal of the Canadian Urological Association |
Volume | 8 |
Issue number | 11-12 |
DOIs |
|
State | Published - Nov 1 2014 |
Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Urology